SMS Lifesciences India Ltd
SMS Lifesciences India Ltd (SMSLIFE) last traded at ₹1,550, a market capitalisation of ₹469 crore, on a P/E of 29.6. Over the past 52 weeks the stock has ranged between ₹1,076 and ₹1,778. SMS Lifesciences India Ltd last reported results for the quarter ended Jun 2026, with sales of ₹72.94 crore and net profit of ₹1.84 crore. SMS Lifesciences India Ltd’s annual general meeting is scheduled for 30 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
SMS Lifesciences India Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
SMS Lifesciences India Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹72.94 cr, down 11.6% from ₹82.5 cr a year earlier. Net profit was ₹1.84 cr, down 58.1% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 78.46 | 84.6 | 89.11 | 82.5 | 81.37 | 94.78 | 75.14 | 72.94 |
| Expenses | 69.89 | 71.85 | 81.69 | 70.79 | 67.79 | 80.73 | 70.98 | 63.82 |
| Operating profit | 8.57 | 12.75 | 7.42 | 11.71 | 13.58 | 14.05 | 4.16 | 9.12 |
| OPM % | 10.92% | 15.07% | 8.33% | 14.19% | 16.69% | 14.82% | 5.54% | 12.50% |
| Other income | 2.04 | 0.06 | 2.34 | 1 | 0.42 | 0.18 | 2.01 | 0.46 |
| Interest | 2.14 | 2.14 | 2.03 | 1.87 | 1.62 | 1.54 | 1.42 | 1.9 |
| Depreciation | 3.76 | 3.76 | 3.8 | 3.82 | 3.89 | 3.91 | 3.85 | 4.24 |
| Profit before tax | 4.71 | 6.91 | 3.93 | 7.02 | 8.49 | 8.78 | 0.9 | 3.44 |
| Tax % | 29.72% | 29.81% | 11.45% | 37.61% | 24.38% | 24.26% | 62.22% | 46.51% |
| Net profit | 3.3 | 4.86 | 3.48 | 4.39 | 6.42 | 6.65 | 0.35 | 1.84 |
| EPS (₹) | 15.45 | 18.09 | 9.82 | 13.76 | 20.18 | 21.90 | 1.46 | 8.77 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
SMS Lifesciences India Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 266 | 350 | 316 | 306 | 345 | 334 | 324 |
| Operating profit | 30 | 35 | 29 | 31 | 45 | 45 | 41 |
| OPM % | 11% | 10% | 9% | 10% | 13% | 13% | 13% |
| Net profit | 14 | 25 | 11 | 6 | 19 | 18 | 15 |
| EPS (₹) | 44.85 | 83.75 | 37.91 | 30.07 | 66.52 | 57.26 | 52.31 |
TTM is the trailing twelve months to the most recent quarter.
SMS Lifesciences India Ltd growth and returns
- 10 Years
- %
- 5 Years
- 5%
- 3 Years
- 2%
- TTM
- -3%
- 10 Years
- %
- 5 Years
- 5%
- 3 Years
- 20%
- TTM
- -8%
- 10 Years
- %
- 5 Years
- 16%
- 3 Years
- 44%
- 1 Year
- 36%
- 10 Years
- %
- 5 Years
- 8%
- 3 Years
- 8%
- Last Year
- 8%
SMS Lifesciences India Ltd shareholding pattern
Promoters held 72.10% at Jun 2026, up from 71.40% at Jun 2025. FIIs 0.00% and DIIs 0.31%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 71.40% | 71.40% | 71.40% | 71.40% | 71.40% | 71.79% | 72.10% | 72.10% |
| FIIs | 0.02% | 0.00% | 0.00% | 0.03% | 0.00% | 0.00% | 0.00% | 0.00% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% | 0.29% | 0.30% | 0.31% |
| Public | 28.57% | 28.59% | 28.60% | 28.56% | 28.57% | 27.91% | 27.59% | 27.58% |
| No. of shareholders | 7,849 | 7,626 | 7,479 | 7,412 | 7,521 | 7,125 | 6,937 | 6,859 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is SMS Lifesciences India Ltd’s AGM?
SMS Lifesciences India Ltd’s annual general meeting is scheduled for 30 Sept 2026.
- AGMHolding the 20th Annual General Meeting
See the full results calendar for every Indian company reporting in the next 30 days.
SMS Lifesciences India Ltd corporate filings
- Enclosed email communication sent to Shareholders.Company Updatelow impact
Cruxal's analysis: Haleos Labs Ltd has issued a standard communication to its shareholders regarding Tax…
Read the full analysis - Enclosed -- newspaper advertisement for Q1F27 results.Company Updatelow impact
Cruxal's analysis: Haleos Labs Limited (formerly SMS Lifesciences India Limited) has published its financial…
Read the full analysis - Mahi Drugs Private Limited appointed Cost Auditors for the year 2026-27 and Mr. Vincent P Asrao as Nominee Director.Company Updatelow impact
Cruxal's analysis: Haleos Labs Ltd has appointed a Cost Auditor for the financial year 2026-27 and…
Read the full analysis - Dr. Mannam Malakondaiah and Dr. Srinivas Samavedam were reappointed for a second term of 5 years w.e.f. November 13, 2026, subject to approval of shareholders.Company Updatelow impact
Cruxal's analysis: Haleos Labs Ltd has proposed the reappointment of Dr. Mannam Malakondaiah and Dr…
Read the full analysis - Enclosed - Outcome of 98th Board meeting.Board Meetingmedium impact
Cruxal's analysis: Haleos Labs Limited (formerly SMS Lifesciences India Limited) reported standalone revenue…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track SMS Lifesciences India Ltd
Cruxal reads every SMS Lifesciences India Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.